6.00
0.405 (7.24%)
0.405 (7.24%)
Upgrade to Real-Time
Afterhours
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Anavex Life Sciences Corporation | AVXL | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.405 | 7.24% | 6.00 | 18:32:09 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 5.98 | 5.49 | 6.01 | 5.65 | 5.595 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 5.95 | 6.00 | 0.05 | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,721 | 935,468 | $ 5.80 | $ 5,427,645 | 1,322,911 | 2.20 - 6.31 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:32:08 | formt | 300 | $ 6.00 | USD |
Anavex Life Sciences Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 361.14M | 60.19M | 57.84M | $ - | $ - | -0.54 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 16.80% |
Anavex Life Sciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AVXL Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.15 | 6.06 | 5.04 | 5.61 | 1,254,372 | 0.85 | 16.5% |
| 1 Month | 4.55 | 6.06 | 3.95 | 4.91 | 1,497,895 | 1.45 | 31.87% |
| 3 Months | 4.99 | 6.06 | 3.6543 | 4.58 | 959,613 | 1.01 | 20.24% |
| 6 Months | 3.37 | 6.06 | 3.05 | 4.48 | 828,958 | 2.63 | 78.04% |
| 1 Year | 2.80 | 6.31 | 2.20 | 3.91 | 882,343 | 3.20 | 114.29% |
| 3 Years | 4.18 | 6.31 | 1.25 | 3.51 | 547,310 | 1.82 | 43.54% |
| 5 Years | 9.60 | 14.8399 | 1.25 | 4.59 | 786,296 | -3.60 | -37.5% |
Anavex Life Sciences Description
| Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company operating in the United States. It is engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including drug candidates to treat Alzheimer's disease, other central nervous systems (CNS) diseases, pain and several types of cancer. The lead compound of the company is ANAVEX 2-73 which is developed to treat Alzheimer's disease, Parkinson's disease and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome. The research and development pipeline of the company includes one clinical drug candidate and several compounds in various stages of the pre-clinical study. |
